Duvyzat®▼ (givinostat): interim advice on risk mitigation measures following reports of deaths in patients while taking givinostat
Imported from official source
There have been several reports internationally of deaths in patients with Duchenne muscular dystrophy (DMD) while being treated with Duvyzat® (givinostat). Following a review of these cases and associated evidence, the MHRA has proposed updates to the product information.
This version
- Version
- 1 of 1
- Recorded
- November 05, 2026 13:02
- Change
- Initial
- Content hash
8717004856b92248c3f056aa52409e71- All versions
- Revision history